The newly-approved Foreign Investment Law, the promotion of free t

rade, further reform and opening up in China have benefited not only foreign investors, but provi

ded a better business environment for all players in this country, said top executives of German pharmaceutical giant

Merck during a media interview at the just-ended Boao Forum for Asia in Boao, South China’s Hainan province.

As a pharmaceutical, chemical and life sciences conglomerate, it is

always important for Merck Group to have clear and transparent pharmaceutical stru

ctures, and the Foreign Investment Law gives the company more transparency and a much more reliable fram

ework, especially on intellectual property rights, said Merck executive board member Kai Beckmann.

“There is a clear focus on the right rules that we have to have, and

we appreciate the progress with the law,” he said, adding that it is what international co

mpanies really appreciate, since it gives them structure and predictability in the operating environment in China.